Andera Partners

Q2 2026 13F-HR Holdings

Location
Paris, I0
Holdings as of
6/30/2026
Date filed
7/22/2026
Form type
13F-HR
Num holdings
8
Total value ($000)
$206,476
Net value change ($000)
+29,560 (16.7%)
New positions
1
Sold out positions
0
Turnover %
14.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/11/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AVALYN PHARMACEUTICALS INC 30,610 NEW
KMTS 15,703 29.2%
AGMB 3,831 23.7%
IVA 3,642 36.1%
ABVX 1,712 19.7%
Top Reduces (Value $000, Stocks/ETFs)
EVMN -25,120 -57.6%
NYXH -642 -42.1%
MLYS -175 -0.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type